1. Home
  2. AFCG vs COCH Comparison

AFCG vs COCH Comparison

Compare AFCG & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AFC Gamma Inc.

AFCG

AFC Gamma Inc.

HOLD

Current Price

$2.75

Market Cap

61.4M

Sector

Real Estate

ML Signal

HOLD

Logo Envoy Medical Inc.

COCH

Envoy Medical Inc.

HOLD

Current Price

$0.71

Market Cap

51.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AFCG
COCH
Founded
2020
1995
Country
United States
United States
Employees
N/A
47
Industry
Real Estate Investment Trusts
Blank Checks
Sector
Real Estate
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
61.4M
51.0M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
AFCG
COCH
Price
$2.75
$0.71
Analyst Decision
Hold
Strong Buy
Analyst Count
2
2
Target Price
$4.50
$6.00
AVG Volume (30 Days)
83.0K
292.7K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
6.94%
N/A
EPS Growth
N/A
N/A
EPS
0.49
N/A
Revenue
$24,563,601.00
N/A
Revenue This Year
$1,334.03
$1.58
Revenue Next Year
$17.33
N/A
P/E Ratio
$5.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.06
$0.36
52 Week High
$5.10
$1.89

Technical Indicators

Market Signals
Indicator
AFCG
COCH
Relative Strength Index (RSI) 43.46 52.71
Support Level $2.49 $0.63
Resistance Level $2.78 $0.74
Average True Range (ATR) 0.12 0.05
MACD 0.03 0.00
Stochastic Oscillator 50.00 48.35

Price Performance

Historical Comparison
AFCG
COCH

About AFCG AFC Gamma Inc.

Advanced Flower Capital Inc is an externally managed Maryland corporation that operates as a Business Development Company (BDC). The firm's primary operations involve originating, structuring, underwriting, and managing senior secured loans and other debt securities. Its investment portfolio includes loans to state law-compliant cannabis operators, ancillary cannabis businesses, and middle-market companies in other industries. These loans are typically secured by collateral such as real estate, equipment, cash flows, and license values.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

Share on Social Networks: